Here are five things to know:
1. The market is expected to increase at a compound annual growth rate of 7.3 percent between 2016 and 2022.
2. In 2015, the market was valued at $1.82 billion.
3. The growing geriatric population is fueling market growth in this region.
4. Last year, the fusion technology segment held a 40.9 percent market share. However, this segment is expected to slow down due to new technologies in the spine biologics segment.
5. China led the market in 2015, with Japan and India trailing behind. In the aforementioned time frame, China is projected to increase at a 7.7 percent CAGR.
More articles on devices:
J&J, Medtronic, St. Jude Medical & more: 17 key notes
A $4B discrepancy: Analysts disagree about how Pfizer’s biosimilar launch will impact Johnson & Johnson’s bottom line
Dr. Thomas Scully performs 1st surgery implanting PRO-LINK Ti system — 6 things to know
